Literature DB >> 19788605

Presence of hepatitis C virus in syringes confiscated in prisons in Australia.

Kate Dolan1, Sarah Larney, Brendan Jacka, William Rawlinson.   

Abstract

BACKGROUND AND AIMS: Needlestick injuries are an occupational hazard for prison officers. This study aimed to assess the presence of hepatitis C virus (HCV) in syringes found in prisons.
METHODS: Sixty-nine syringes found in prisons were tested for HCV RNA using previously published methods.
RESULTS: Three syringes tested positive for HCV RNA.
CONCLUSION: Compared to the prevalence of HCV among injecting drug users in prisons, few syringes were found to contain HCV RNA. It is likely that conditions under which syringes are kept in prisons are not favorable for survival of detectable HCV RNA. Further work is needed to establish the risk of HCV transmission posed by needlestick injuries in prison settings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19788605     DOI: 10.1111/j.1440-1746.2009.05978.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  3 in total

Review 1.  Substance Use and HIV Among Female Sex Workers and Female Prisoners: Risk Environments and Implications for Prevention, Treatment, and Policies.

Authors:  Steffanie A Strathdee; Brooke S West; Elizabeth Reed; Babak Moazen; Babak Moazan; Tasnim Azim; Kate Dolan
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

2.  Incidence and risk for acute hepatitis C infection during imprisonment in Australia.

Authors:  Kate Dolan; Suzy Teutsch; Nicolas Scheuer; Michael Levy; William Rawlinson; John Kaldor; Andrew Lloyd; Paul Haber
Journal:  Eur J Epidemiol       Date:  2010-02       Impact factor: 8.082

3.  Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain.

Authors:  Sam Shirley-Beavan; Aura Roig; Naomi Burke-Shyne; Colleen Daniels; Robert Csak
Journal:  Harm Reduct J       Date:  2020-10-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.